CN113372579B - 可注射大孔水凝胶 - Google Patents

可注射大孔水凝胶 Download PDF

Info

Publication number
CN113372579B
CN113372579B CN202110629796.7A CN202110629796A CN113372579B CN 113372579 B CN113372579 B CN 113372579B CN 202110629796 A CN202110629796 A CN 202110629796A CN 113372579 B CN113372579 B CN 113372579B
Authority
CN
China
Prior art keywords
peg
gel
solute
macroporous
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110629796.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN113372579A (zh
Inventor
N·布洛克里
M·泽诺比-黄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eidgenoessische Technische Hochschule Zurich ETHZ
Original Assignee
Eidgenoessische Technische Hochschule Zurich ETHZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eidgenoessische Technische Hochschule Zurich ETHZ filed Critical Eidgenoessische Technische Hochschule Zurich ETHZ
Priority to CN202110629796.7A priority Critical patent/CN113372579B/zh
Publication of CN113372579A publication Critical patent/CN113372579A/zh
Application granted granted Critical
Publication of CN113372579B publication Critical patent/CN113372579B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C08J9/286—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum the liquid phase being a solvent for the monomers but not for the resulting macromolecular composition, i.e. macroporous or macroreticular polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/08—Polyethers derived from hydroxy compounds or from their metallic derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/02—Dextran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/54—Aqueous solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202110629796.7A 2015-09-09 2016-09-08 可注射大孔水凝胶 Active CN113372579B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110629796.7A CN113372579B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15184552 2015-09-09
EP15184552.6 2015-09-09
CN201680051583.8A CN108025110B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶
PCT/EP2016/071238 WO2017042301A1 (en) 2015-09-09 2016-09-08 Injectable macroporous hydrogels
CN202110629796.7A CN113372579B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680051583.8A Division CN108025110B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶

Publications (2)

Publication Number Publication Date
CN113372579A CN113372579A (zh) 2021-09-10
CN113372579B true CN113372579B (zh) 2023-07-14

Family

ID=54150245

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202110629796.7A Active CN113372579B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶
CN201680051583.8A Active CN108025110B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680051583.8A Active CN108025110B (zh) 2015-09-09 2016-09-08 可注射大孔水凝胶

Country Status (19)

Country Link
US (1) US20180264176A1 (https=)
EP (2) EP3347061B1 (https=)
JP (1) JP6829898B2 (https=)
CN (2) CN113372579B (https=)
AU (1) AU2016320395B2 (https=)
CA (1) CA2992692C (https=)
CY (1) CY1124571T1 (https=)
DK (2) DK3347061T3 (https=)
ES (1) ES2883235T3 (https=)
HR (1) HRP20211306T1 (https=)
HU (1) HUE055937T2 (https=)
IL (1) IL257024B (https=)
LT (1) LT3347061T (https=)
PL (1) PL3347061T3 (https=)
PT (1) PT3347061T (https=)
RS (1) RS62239B1 (https=)
SI (1) SI3347061T1 (https=)
SM (1) SMT202100470T1 (https=)
WO (1) WO2017042301A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2622594B1 (en) 2010-10-01 2018-08-22 Applied Medical Resources Corporation Portable laparoscopic trainer
KR101963610B1 (ko) 2011-10-21 2019-03-29 어플라이드 메디컬 리소시스 코포레이션 수술 트레이닝용 모의 조직 구조
JP2015503961A (ja) 2011-12-20 2015-02-05 アプライド メディカル リソーシーズ コーポレイション 高度手術シミュレーション
US10535281B2 (en) 2012-09-26 2020-01-14 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
US10679520B2 (en) 2012-09-27 2020-06-09 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
ES2864157T3 (es) 2012-09-27 2021-10-13 Applied Med Resources Modelo de entrenamiento quirúrgico para procedimientos laparoscópicos
EP3660816B1 (en) 2013-03-01 2021-10-13 Applied Medical Resources Corporation Advanced surgical simulation constructions and methods
EP3011550B1 (en) 2013-06-18 2018-01-03 Applied Medical Resources Corporation Gallbladder model
US10198966B2 (en) 2013-07-24 2019-02-05 Applied Medical Resources Corporation Advanced first entry model for surgical simulation
JP6517201B2 (ja) 2013-07-24 2019-05-22 アプライド メディカル リソーシーズ コーポレイション ファーストエントリーモデル
KR102581212B1 (ko) 2014-03-26 2023-09-21 어플라이드 메디컬 리소시스 코포레이션 시뮬레이션된 절개가능 조직
EP3218892B1 (en) 2014-11-13 2019-10-23 Applied Medical Resources Corporation Simulated tissue models and methods
ES2732722T3 (es) 2015-02-19 2019-11-25 Applied Med Resources Estructuras tisulares simuladas y métodos
EP3476343B1 (en) 2015-05-14 2022-12-07 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
US12512017B2 (en) 2015-05-27 2025-12-30 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
WO2016201085A1 (en) 2015-06-09 2016-12-15 Applied Medical Resources Corporation Hysterectomy model
CA3249585A1 (en) 2015-07-16 2025-02-24 Applied Medical Resources Corporation Simulated dissectable tissue
KR102646090B1 (ko) 2015-07-22 2024-03-12 어플라이드 메디컬 리소시스 코포레이션 충수절제술 모델
EP3357054B1 (en) 2015-10-02 2023-08-30 Applied Medical Resources Corporation Hysterectomy model
EP3378053B1 (en) 2015-11-20 2023-08-16 Applied Medical Resources Corporation Simulated dissectible tissue
EP4151661A1 (en) 2016-03-24 2023-03-22 Takeda Pharmaceutical Company Limited Alginate hydrogel compositions
JP6925579B2 (ja) * 2016-03-31 2021-08-25 日油株式会社 環状ベンジリデンアセタール構造を有する生分解性ヒドロゲル
WO2018005301A1 (en) 2016-06-27 2018-01-04 Applied Medical Resources Corporation Simulated abdominal wall
JP7125398B2 (ja) 2016-12-13 2022-08-24 ミレニアム ファーマシューティカルズ， インコーポレイテッド 生体表面のコンフォーマルコーティング
WO2018152122A1 (en) 2017-02-14 2018-08-23 Applied Medical Resources Corporation Laparoscopic training system
US10847057B2 (en) 2017-02-23 2020-11-24 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
EP3681636A1 (en) * 2017-09-11 2020-07-22 Evorion Biotechnologies GmbH Systems, methods and hydrogels for cell culture and analysis
CN108893445A (zh) * 2018-07-26 2018-11-27 南方医科大学 一种引导视网膜神经节细胞及其轴突生长延展的方法
CN109316628B (zh) * 2018-09-21 2021-04-20 广州远想生物科技有限公司 一种凝胶及其制备方法和应用
CN109731133B (zh) * 2019-02-01 2020-09-01 浙江大学 一种抗菌、抗粘附、可注射式温敏壳聚糖凝胶敷料及其制备方法
US11680107B2 (en) * 2019-03-22 2023-06-20 Taipei Medical University Hydrogel composition for drug delivery and uses thereof
EP3958907A1 (en) 2019-08-28 2022-03-02 Boston Scientific Scimed Inc. Multi-armed polyoxazolines and compositions, systems and methods pertaining to the same
US20230051239A1 (en) * 2020-01-03 2023-02-16 Repertoire Immune Medicines, Inc. Compositions of hydrogels and methods of use thereof
CA3168506A1 (en) * 2020-01-28 2021-08-05 The University Of Tokyo Gel material for regenerative medicine
CN112898600B (zh) * 2021-02-07 2023-05-23 西安工业大学 一种聚多巴胺可逆粘附凝胶的分相制备方法
JP2023020949A (ja) * 2021-07-28 2023-02-09 東ソー株式会社 細胞培養用表面処理剤
WO2023135155A1 (en) 2022-01-12 2023-07-20 Eth Zurich Photocurable phase-separating hydrogels
EP4536801A1 (en) 2022-06-13 2025-04-16 ETH Zurich Collagen visualization on microfluidic device
EP4616875A1 (en) 2024-03-12 2025-09-17 Novonexile AG Semi-interpenetrating polymer networks

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1668697A (zh) * 2001-11-07 2005-09-14 苏黎世大学 用于控制细胞向内生长和组织再生的合成基质
CN1835792A (zh) * 2003-01-17 2006-09-20 康乃尔研究基金会有限公司 含水两相体系的可注射水凝胶微球
CN1918219A (zh) * 2004-02-03 2007-02-21 安特易斯有限公司 生物相容性交联凝胶
CN102573941A (zh) * 2009-07-30 2012-07-11 卡比兰生物外科公司 改性透明质酸聚合物组合物和相关的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070264227A1 (en) * 2001-11-07 2007-11-15 Eidgenossische Technische Hochschule Zurich Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration
MXPA04006021A (es) * 2001-12-18 2005-08-19 Eth Zuerich Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.
KR100699278B1 (ko) * 2005-05-12 2007-03-23 학교법인 포항공과대학교 수화젤레이터로 유용한 바이오틴-아미노산 결합체 및이로부터 제조된 수화젤
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
EP2498763A4 (en) * 2009-11-09 2015-10-07 Spotlight Technology Partners Llc HYDROGELE ON POLYSACCHARIDBASIS
JP6104806B2 (ja) * 2010-10-06 2017-03-29 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 材料に基づく細胞治療のための注射可能孔形成性ハイドロゲル
US9416228B2 (en) * 2012-03-16 2016-08-16 Bender Analytical Holding B.V. Cross-linked polymers and medical products derived from nucleophilically activated polyoxazoline
PL2916881T3 (pl) * 2012-11-07 2020-05-18 Eth Zurich Siarczanowane hydrożele alginianowe do hodowli i terapii komórkowych

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1668697A (zh) * 2001-11-07 2005-09-14 苏黎世大学 用于控制细胞向内生长和组织再生的合成基质
CN1835792A (zh) * 2003-01-17 2006-09-20 康乃尔研究基金会有限公司 含水两相体系的可注射水凝胶微球
CN1918219A (zh) * 2004-02-03 2007-02-21 安特易斯有限公司 生物相容性交联凝胶
CN102573941A (zh) * 2009-07-30 2012-07-11 卡比兰生物外科公司 改性透明质酸聚合物组合物和相关的方法

Also Published As

Publication number Publication date
HUE055937T2 (hu) 2022-01-28
AU2016320395B2 (en) 2020-09-17
EP3347061A1 (en) 2018-07-18
SMT202100470T1 (it) 2021-09-14
ES2883235T3 (es) 2021-12-07
CN113372579A (zh) 2021-09-10
HRP20211306T1 (hr) 2021-11-26
EP3868416A1 (en) 2021-08-25
DK3347061T3 (da) 2021-08-23
IL257024B (en) 2022-02-01
EP3347061B1 (en) 2021-05-19
CN108025110A (zh) 2018-05-11
CN108025110B (zh) 2021-08-20
DK3868416T3 (da) 2022-10-31
CA2992692C (en) 2021-12-21
PT3347061T (pt) 2021-08-25
PL3347061T3 (pl) 2021-11-22
IL257024A (en) 2018-03-29
WO2017042301A1 (en) 2017-03-16
AU2016320395A1 (en) 2018-02-22
SI3347061T1 (sl) 2021-11-30
RS62239B1 (sr) 2021-09-30
JP2018535704A (ja) 2018-12-06
EP3868416B1 (en) 2022-08-10
CA2992692A1 (en) 2017-03-16
CY1124571T1 (el) 2022-07-22
JP6829898B2 (ja) 2021-02-17
US20180264176A1 (en) 2018-09-20
LT3347061T (lt) 2021-09-10

Similar Documents

Publication Publication Date Title
CN113372579B (zh) 可注射大孔水凝胶
US11511016B2 (en) Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery
Lee et al. Advanced gellan gum-based glycol chitosan hydrogel for cartilage tissue engineering biomaterial
Tang et al. Mussel-inspired injectable hydrogel and its counterpart for actuating proliferation and neuronal differentiation of retinal progenitor cells
Fiorica et al. Hyaluronic acid and beta cyclodextrins films for the release of corneal epithelial cells and dexamethasone
He et al. Fabrication of oxidized sodium alginate-collagen heterogeneous bilayer barrier membrane with osteogenesis-promoting ability
US20130142763A1 (en) Crosslinked cellulosic polymers
Nguyen et al. Anti-inflammatory effects of sodium alginate/gelatine porous scaffolds merged with fucoidan in murine microglial BV2 cells
WO2021041372A1 (en) Universal orthogonal network bioinks for three-dimensional bioprinting
Ramos Ferrer et al. Sustained neurotrophin‐3 delivery from hyaluronic acid hydrogels for neural tissue regeneration
US10576042B2 (en) Composition comprising polyelectrolyte complexes, methods and uses thereof
Zhu et al. Dopamine-functionalized bioinspired pre-chondrogenic hydrogel for cell-free cartilage regeneration
Srisuk Alginate based composite scaffold for biomedical engineering applications
Diamond Decellularized Porcine Brain Matrix for Neural Tissue Engineering
Pizzolitto SVILUPPO E CARATTERIZZAZIONE DI STRUTTURE 3D E DI IDROGELI A BASE DI POLISACCARIDI NATURALI E MODIFICATI E LORO APPLICAZIONE IN CAMPO BIOMEDICO
Smith Cellular hitchhiking via injectable microparticles
Liu et al. Photosensitive and extracellular matrix-mimicking hydrogels promote the tendon-bone healing in rotator cuff injury
WO2025099175A1 (de) Lebendes kompositmaterial für medizinische produkte
DE102023131356A1 (de) Lebendes Kompositmaterial für medizinische Produkte
ALPES Hydrogels multi-fonctionnels à base d'acide hyaluronique pour le contrôle de l’adhésion, la prolifération et la différentiation de cellules souches neuronales
Shi Differentiation of neural stem cell using small molecules in 2D and 3D culture system
Ramos Ferrer et al. Injectable Hyaluronic Acid-Based Hydrogels for Sustained Neurotrophin-3 Delivery to Promote 3-Dimensional Axon Growth

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant